M. Kulyk & Associates, LLC Novo Nordisk A S Transaction History
M. Kulyk & Associates, LLC
- $422 Million
- Q1 2025
A detailed history of M. Kulyk & Associates, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 65,897 shares of NVO stock, worth $4.44 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
65,897
Previous 3,182
1970.93%
Holding current value
$4.44 Million
Previous $273,000
1575.82%
% of portfolio
1.08%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.27 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$996 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$834 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$830 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$800 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $152B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...